345237-12-9

Upstream product

• 18905-24-3 p-aminophenylguanidine 
• 53855-64-4 3-acetoxy-2-naphthoyl chloride 
• 55894-14-9 (4-amino-phenyl)-guanidine; hydrochloride 
• 879-18-5 naphthalene-1-carbonic acid chloride 
• 92-70-6 3-Hydroxy-2-naphthoic acid 
• 5464-07-3 3-acetoxy-2-naphthoic acid 

Relevant academic research and scientific papers

Salicylamides as serine protease inhibitors

The present invention provides novel compounds of Formula I: its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa),

4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors

The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described.